N-Ethyl-N-Nitrosourea Induced Leukaemia in a Mouse Model: Protective Effect of Icaritin via Inhibition of IL-6/JAK2/STAT3 Pathway Causes Apoptosis

References

• Prakash G, Bhattacharjee U, Ck D. Chronic myeloid leukemia blast crisis: an emergency. Onco-Critical Care. 2022;74:271–277.
   Google Scholar
• Haferlach C, Rieder H, Lillington DM, et al. Proposals for standardized protocols for cytogenetic analyses of acute leukemias. Chronic Lymphocytic Leukemia. 2007;46(5):494–499.
   Google Scholar
• Rausch CR, DiPippo AJ, Jiang Y, et al. Comparison of mold active triazoles as primary antifungal prophylaxis in patients with newly diagnosed acute myeloid leukemia in the era of molecularly targeted therapies; 2022.;
   Google Scholar
• Nath P, Modak S, Akter T, Maiti DJIJOP, Sciences A. Effects of N Ethyl N′ nitrosourea in mice brain in time fashion: effect of ENU in brain. Indian J Physiol. 2022;74:1.
   Google Scholar
• Vohra N, Chavez T, Troncoso JR, et al. Mammary tumors in Sprague Dawley rats induced by N-ethyl-N-nitrosourea for evaluating terahertz imaging of breast cancer. J Med Im. 2021;8(2):023504. doi:10.1117/1.JMI.8.2.023504
   Web of Science ®Google Scholar
• Martinez A, Merchan J, Sala M, et al. Carcinogénesis y nitrosoamidas. Patolog. 1974; 7:225–230.
   Google Scholar
• Slikker III W, Mei N, Chen TJTS. N-ethyl-N-nitrosourea (ENU) increased brain mutations in prenatal and neonatal mice but not in the adults. Toxicol Sci. 2004;81(1):112–120.
   PubMed Web of Science ®Google Scholar
• Bulnes S, Bermúdez G, Lafuente JVJO. Association of Notch-1. Steo Stem-Like Cells ENU-Glioma Malig Proc. 2018;9(59):31330.
   Google Scholar
• Kumar CC. Genetic abnormalities and challenges in the treatment of acute myeloid leukemia. Genes Cancer. 2011;2(2):95–107. doi:10.1177/1947601911408076
   PubMedGoogle Scholar
• Huang B, Lang X, Li X. The role of IL-6/JAK2/STAT3 signaling pathway in cancers. Front Oncol. 2022;12:1023177. doi:10.3389/fonc.2022.1023177
   PubMedGoogle Scholar
• Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9(11):798–809. doi:10.1038/nrc2734
   PubMed Web of Science ®Google Scholar
• Wang Y, Zheng N, Sun T, Zhao H, Chen Y, Liu CJMMR. Role of TGM2 in T‑cell lymphoblastic lymphoma via regulation of IL‑6/JAK/STAT3 signalling. Mol Med Rep. 2022;25(3):1–9.
   PubMed Web of Science ®Google Scholar
• Xu L, Yao Y, Lu T, LJJom J. interactions n. miR-451a targeting IL-6R activates JAK2/STAT3 pathway, thus regulates proliferation and apoptosis of multiple myeloma cells. Journal of Musculoskeletal & Neuronal Interactions. 2022;22(2):251–260.
   PubMed Web of Science ®Google Scholar
• Wu X-Y, Tian F, Su M-H, et al. BF211, a derivative of bufalin, enhances the cytocidal effects in multiple myeloma cells by inhibiting the IL-6/JAK2/STAT3 pathway. Int Immunopharmacol. 2018; 64(24–32):1.
   PubMedGoogle Scholar
• Sheikh IN, Ragoonanan D, Franklin A, et al. Cardiac relapse of acute lymphoblastic leukemia following hematopoietic stem cell transplantation: a case report and review of literature. Cancers. 2021;13(22):5814. doi:10.3390/cancers13225814
   PubMed Web of Science ®Google Scholar
• Allodji RS, Tucker MA, Hawkins MM, et al. Role of radiotherapy and chemotherapy in the risk of leukemia after childhood cancer: an international pooled analysis. International Journal of Cancer. 2021;148(9):2079–2089. doi:10.1002/ijc.33361
   PubMed Web of Science ®Google Scholar
• Piktel D, Nair RR, Rellick SL, et al. Pitavastatin is anti-leukemic in a bone marrow microenvironment model of b-lineage acute lymphoblastic Leukemia. Cancers. 2022;14(11):2681. doi:10.3390/cancers14112681
   PubMed Web of Science ®Google Scholar
• Bukhari S, Siddique MH, Naeem A, et al. Combined efficacy of Cinnamomum zeylanicum and doxorubicin against leukemia through regulation of TRAIL and NF-kappa B pathways in rat model. Mol Biol Rep. 2022; 49:1–13.
   PubMed Web of Science ®Google Scholar
• Maher T, Ahmad Raus R, Daddiouaissa D, et al. Medicinal Plants with anti-leukemic effects: a review. Molecules. 2021;26(9):2741. doi:10.3390/molecules26092741
   PubMed Web of Science ®Google Scholar
• Gao L, Zhang SQ, Effects A. Pharmacokinetics, and drug delivery systems of icaritin: advances and prospects. Pharmaceuticals. 2022;154: 1. doi:10.3390/ph15040397
   Web of Science ®Google Scholar
• Liu S, Liu C, Xiong L, et al. Icaritin alleviates glutamate-induced neuronal damage by inactivating GluN2B-containing NMDARs through the ERK/DAPK1 pathway. Front Neurosci. 2021;15:525615. doi:10.3389/fnins.2021.525615
   PubMed Web of Science ®Google Scholar
• Wo Y, Zhu D, Hu Y, Wang ZQ, Liu J, Lou Y. Reactive oxygen species involved in prenylflavonoids, icariin and icaritin, initiating cardiac differentiation of mouse embryonic stem cells. J Cellular Bioche. 2008;103(5):1536–1550. doi:10.1002/jcb.21541
   PubMed Web of Science ®Google Scholar
• Liu S, Guo Y, Wang J, et al. A novel anticancer agent SNG1153 inhibits growth of lung cancer stem/progenitor cells. Oncotarget. 2016;7(29):45158. doi:10.18632/oncotarget.9783
   PubMedGoogle Scholar
• Zhu J, Li Z, Zhang G, et al. Icaritin shows potent anti-leukemia activity on chronic myeloid leukemia in vitro and in vivo by regulating MAPK/ERK/JNK and JAK2/STAT3/AKT signalings. PLoS One. 2011;6(8): e23720. doi:10.1371/journal.pone.0023720
   PubMed Web of Science ®Google Scholar
• Aliyu A, Shaari MR, Ahmad Sayuti NS, et al. N-Ethyl-n-Nitrosourea induced Leukaemia in a mouse model through upregulation of vascular endothelial growth factor and evading apoptosis. Cancers. 2020;12(3):678. doi:10.3390/cancers12030678
   PubMed Web of Science ®Google Scholar
• Li S, Priceman SJ, Xin H, et al. Icaritin inhibits JAK/STAT3 signaling and growth of renal cell carcinoma. PLoS One. 2013;8(12): e81657. doi:10.1371/journal.pone.0081657
   PubMed Web of Science ®Google Scholar
• Kayser S, Levis M. Updates on targeted therapies for acute myeloid leukaemia. British J Haematol. 2022;196(2):316–328. doi:10.1111/bjh.17746
   PubMed Web of Science ®Google Scholar
• Shallis RM, Wang R, Davidoff A, Ma X, Zeidan A. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Reviews. 2019;36:70–87. doi:10.1016/j.blre.2019.04.005
   PubMed Web of Science ®Google Scholar
• Bhatia S. Therapy-Related Myelodysplasia and Acute Myeloid Leukemia. Elsevier; 2013:666–675.
   Google Scholar
• Aliyu A, Shaari MR, Mustapha NM, et al. Some chemical carcinogens for leukaemia induction and their animal models. Annual Res. 2019; 2019:1–7.
   Google Scholar
• Nath P, DJJoB M. A review of the mutagenic potential of N‐ethyl‐N‐nitrosourea (ENU) to induce hematological malignancies. J Biochem Molecu Toxicol. 2022;36(7): e23067. doi:10.1002/jbt.23067
   PubMed Web of Science ®Google Scholar
• Kennedy CL, MKJHru O. N-ethyl-N-nitrosourea (ENU) mutagenesis and male fertility research. Human Reprod Update. 2006;12(3):293–301. doi:10.1093/humupd/dmk004
   PubMed Web of Science ®Google Scholar
• Wang J, Liu X, Heflich RH, Tjts C. Time course of cII gene mutant manifestation in the liver, spleen, and bone marrow of N-ethyl-N-nitrosourea-treated big blue transgenic mice. Toxicol Sci. 2004;82(1):124–128. doi:10.1093/toxsci/kfh234
   PubMed Web of Science ®Google Scholar
• Rathkolb B, Klempt M, Sabrautzki S, et al. Screen for alterations of iron related parameters in N-ethyl-N-nitrosourea-treated mice identified mutant lines with increased plasma ferritin levels. Biometals. 2015;28(2):293–306. doi:10.1007/s10534-015-9824-1
   PubMed Web of Science ®Google Scholar
• Abou Elazab MF, Elbaiomy AE, Ahmed MS, et al. Ameliorative effects of bovine lactoferrin on benzene-induced hematotoxicity in albino rats. Veteri Sci. 2022; 9(5): doi:10.3390/vetsci9050240
   Google Scholar
• Van Etten RA. Aberrant cytokine signaling in leukemia. Oncogene. 2007;26(47):6738–6749. doi:10.1038/sj.onc.1210758
   PubMed Web of Science ®Google Scholar
• Kartikasari AE, Huertas CS, Mitchell A, Plebanski MJFi O. Tumor-induced inflammatory cytokines and the emerging diagnostic devices for cancer detection and prognosis. Front Oncol. 2021; 11.
   Web of Science ®Google Scholar
• Zhang CC, Lodish HF. Cytokines regulating hematopoietic stem cell function. Current Opinion Hematol. 2008;15(4):307–311. doi:10.1097/MOH.0b013e3283007db5
   PubMed Web of Science ®Google Scholar
• Parajuli B, Sonobe Y, Kawanokuchi J, et al. GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia J Neuroinflam. 2012;9(1):1–12.
   PubMedGoogle Scholar
• Reynaud D, Pietras E, Barry-Holson K, et al. IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development. Cancer Cell. 2011;20(5):661–673. doi:10.1016/j.ccr.2011.10.012
   PubMed Web of Science ®Google Scholar
• Hu J, Yang T, Xu H, Hu M, Wen H, Jiang H. A novel anticancer agent icaritin inhibited proinflammatory cytokines in TRAMP mice. Int Urol Nephrol. 2016;48(10):1649–1655. doi:10.1007/s11255-016-1341-9
   PubMed Web of Science ®Google Scholar
• Zhou J, Ching YQ, Chng WJ. Aberrant nuclear factor-kappa B activity in acute myeloid leukemia: from molecular pathogenesis to therapeutic target. Oncotarget. 2015;6(8):5490–5500. doi:10.18632/oncotarget.3545
   PubMed Web of Science ®Google Scholar
• Zhang T, Ma C, Zhang Z, Zhang H, Hu H. NF-κB signaling in inflammation and cancer. Med Comm. 2021;2(4):618–653. doi:10.1002/mco2.104
   Google Scholar
• Liu L, Zhao Z, Lu L, et al. Icariin and icaritin ameliorated hippocampus neuroinflammation via inhibiting HMGB1-related pro-inflammatory signals in lipopolysaccharide-induced inflammation model in C57BL/6 J mice. Int Immunol. 2019;68:95–105. doi:10.1016/j.intimp.2018.12.055
   Google Scholar
• Johnson DE, Ra O, Grandis JR. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15(4):234–248. doi:10.1038/nrclinonc.2018.8
   PubMed Web of Science ®Google Scholar
• Yang J-G, Lu R, X-J Y, Zhang J, Tan Y-Q, Zhou G. Icaritin reduces oral squamous cell carcinoma progression via the inhibition of STAT3 signaling. Int J Mol Sci. 2017;18(1):132. doi:10.3390/ijms18010132
   PubMed Web of Science ®Google Scholar
• Park C, Moon D-O, Rhu C-H, et al. Beta-sitosterol induces anti-proliferation and apoptosis in human leukemic U937 cells through activation of caspase-3 and induction of Bax/Bcl-2 ratio. Bio Phar Bulle. 2007;30(7):1317–1323. doi:10.1248/bpb.30.1317
   PubMed Web of Science ®Google Scholar
• Tong J-S, Zhang Q-H, Huang X, et al. Icaritin causes sustained ERK1/2 activation and induces apoptosis in human endometrial cancer cells. PLoS One. 2011;6(3): e16781. doi:10.1371/journal.pone.0016781
   PubMed Web of Science ®Google Scholar
• Guo Y, Zhang X, Meng J, Wang Z-Y. An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells. Eur J Pharmacol. 2011;658(2–3):114–122. doi:10.1016/j.ejphar.2011.02.005
   PubMed Web of Science ®Google Scholar